| Literature DB >> 29165333 |
Ekaterina Korotkova1,2, Majid Laassri3, Tatiana Zagorodnyaya4, Svetlana Petrovskaya5, Elvira Rodionova6, Elena Cherkasova7, Anatoly Gmyl8,9, Olga E Ivanova10,11, Tatyana P Eremeeva12, Galina Y Lipskaya13, Vadim I Agol14,15, Konstantin Chumakov16.
Abstract
Complete genomic sequences of a non-redundant set of 70 recombinants between three serotypes of attenuated Sabin polioviruses as well as location (based on partial sequencing) of crossover sites of 28 additional recombinants were determined and compared with the previously published data. It is demonstrated that the genomes of Sabin viruses contain distinct strain-specific segments that are eliminated by recombination. The presumed low fitness of these segments could be linked to mutations acquired upon derivation of the vaccine strains and/or may have been present in wild-type parents of Sabin viruses. These "weak" segments contribute to the propensity of these viruses to recombine with each other and with other enteroviruses as well as determine the choice of crossover sites. The knowledge of location of such segments opens additional possibilities for the design of more genetically stable and/or more attenuated variants, i.e., candidates for new oral polio vaccines. The results also suggest that the genome of wild polioviruses, and, by generalization, of other RNA viruses, may harbor hidden low-fitness segments that can be readily eliminated only by recombination.Entities:
Keywords: attenuation; reversion; vaccine-derived polioviruses; vaccine-induced adverse reactions; virulence
Mesh:
Substances:
Year: 2017 PMID: 29165333 PMCID: PMC5707560 DOI: 10.3390/v9110353
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Overview of the set of analyzed intertypic recombinants.
| Our Study | Published Data | Total | |||
|---|---|---|---|---|---|
| Number of isolates | 70 | 28 | 33 | 58 | 189 |
| Number (%) of type 1, type 2, and type 3 isolates | 8 (11), | 2 (7), | 3 (9), | 1 (2), | 14 (8), |
| 30 (43), | 9 (32), | 13 (39), | 26 (45), | 78 (41), | |
| 32 (46) | 17 (61) | 17 (52) | 31 (53) | 97 (51) | |
| Number (%) of VDPV | 5 (7) | ? | 15 (45) | ? | ? |
| Number (%) of Sabin-like strains | 65 (93) | ? | 18 (55) | ? | ? |
| Number (%) of AFP cases | 40 (57) | 20 (71) | 24 (73) | 20 (34) | 104 (55) |
| Number (%) of isolates from patients with other diagnoses | 6 (9) | 4 (14) | 1 (3) | - | 11 (6) |
| Number (%) of isolates from healthy persons | 12 (17) | 1 (4) | 7 (21) | 16 (28) | 36 (19) |
| Number (%) of isolates from sewage | 9 (13) | 3 (11) | 1 (3) | 11 (19) | 24 (13) |
| Number (%) of strains of unknown origin | 3 (4) | - | - | 11 (19) | 14 (7) |
VDPV, vaccine-derived poliovirus; AFP, acute flaccid paralysis.
Figure 1Schematic representation of the genome structures of recombinants of serotypes 1 (A), 2 (B), and 3 (C). Sequences derived from these serotypes are depicted in red, orange, and green respectively. In each panel, the genomes are shown that were sequenced fully (a) and partially (b) in this study, fully sequenced from Genbank (c), and partially sequenced previously (d). The occurrence of additional crossovers in the partially sequenced genomes could not be ruled out. The presence of foreign sequences in the genomes of recombinants of a given serotype is summarized in (e). The functional genetic map of the poliovirus genome is given at the bottom of each panel. Heavier and lighter shading refer to the proposed “weak” and “provisionally weak” genomic areas (see text). UTR, untranslated region.
Figure 2The occurrence of type-specific genomic segments in the normalized common set of recombinants of all three serotypes. The set of recombinants of each serotype is normalized to 1. Sequences derived from these serotypes are depicted in red, orange, and green respectively.
Figure 3Location of known attenuating mutations (red triangles), an often-reverted serotype-1-specific mutation (black triangle) and mutations acquired upon the derivation of vaccine strains (vertical lines) in the genomes of Sabin viruses. Regions speculated to determine a decreased fitness are highlighted as blue rectangles. Their darker and lighter shading refer to the proposed “weak” and “provisionally weak” genomic areas (see Figure 1). The schematic representation of poliovirus genome and its functional elements are given at the bottom.
Loss of attenuating and/or temperature-sensitive (ts) mutations in the set of recombinants with the fully sequenced genomes.
| Serotype | Location of Mutation | Attenuating Mutations Lost, % | |
|---|---|---|---|
| In the Retained Part of the Genome | In the Removed Part of the Genome | ||
| 1 | 480 | 67 | - |
| 525 | 11 | - | |
| 935 | 22 | - | |
| 2438 | 33 | - | |
| 2741 | 22 | - | |
| 2795 | 67 | - | |
| 2879 | 0 | - | |
| 6203 | 9 | 82 | |
| 7071 | 8 | 25 | |
| 2 | 398 | 49 | - |
| 481 | 100 | - | |
| 2908 | 5 | - | |
| 2909 | 85 | - | |
| 3 | 472 | 98 | - |
| 2034 | 20 | - | |
| 2493 a | 100 | - | |
a 2493-U is present in some vaccines [32], therefore this mutation does not necessarily represent reversion during several virus transmission.
Figure 4Schematic representation of the possible 3′-terminal tertiary structures of the RNAs of Sabin-2 (A) and Sabin-3 (B) polioviruses. It shows the helical elements of hairpins X and Y as well as the tertiary kissing interaction between these hairpins (K). The nucleotides distinguishing these two 3′UTRs are highlighted in red. Of note, these distinctive nucleotides in Sabin 1 RNA are the same as in Sabin 3. Modified from [35].
Figure 5The location of all intertypic crossover sites in the analyzed recombinants. The number of respective crossovers is given on the vertical axes. Schematic genome maps are also presented. In this and the following Figure the data from [12] are also included.
Figure 6The dependence of the frequency of crossovers on the length of homologous sequences in the relevant regions of the recombining partners. Peaks corresponding to homology lengths of 2, 5, 8, etc. are caused by the fact that the most often difference between sequences of 3 serotypes concerns the third positions of the codons.